Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
- PMID: 33045394
- PMCID: PMC7546688
- DOI: 10.1016/j.hjc.2020.09.015
Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
Abstract
The perception that women represent a low-risk population for cardiovascular (CV) disease (CVD) needs to be reconsidered. Starting from risk factors, women are more likely to be susceptible to unhealthy behaviors and risk factors that have different impact on CV morbidity and mortality as compared to men. Despite the large body of evidence as regards the effect of lifestyle factors on the CVD onset, the gender-specific effect of traditional and non-traditional risk factors on the prognosis of patients with already established CVD has not been well investigated and understood. Furthermore, CVD in women is often misdiagnosed, underestimated, and undertreated. Women also experience hormonal changes from adolescence till elder life that affect CV physiology. Unfortunately, in most of the clinical trials women are underrepresented, leading to the limited knowledge of CV and systemic impact effects of several treatment modalities on women's health. Thus, in this consensus, a group of female cardiologists from the Hellenic Society of Cardiology presents the special features of CVD in women: the different needs in primary and secondary prevention, as well as therapeutic strategies that may be implemented in daily clinical practice to eliminate underestimation and undertreatment of CVD in the female population.
Keywords: Cardiovascular; Heart disease; Primary prevention; Secondary prevention; Women.
Copyright © 2020 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Women in cardiology.Hellenic J Cardiol. 2020 Nov-Dec;61(6):378-379. doi: 10.1016/j.hjc.2021.02.008. Epub 2021 Feb 20. Hellenic J Cardiol. 2020. PMID: 33617962 No abstract available.
-
Invasive therapies in women.Hellenic J Cardiol. 2020 Nov-Dec;61(6):380. doi: 10.1016/j.hjc.2021.02.009. Hellenic J Cardiol. 2020. PMID: 33771327 No abstract available.
References
-
- Gong I.Y., Tan N.S., Ali S.H. Temporal trends of women enrollment in major cardiovascular randomized clinical trials. Can J Cardiol. 2019;35:653–660. - PubMed
-
- Scott P.E., Unger E.F., Jenkins M.R. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol. 2018;71:1960–1969. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
